Total Funding
91
76
Total FundingVenture - Series Unknown raised
Growth Score 91 in past quarter
-3 pts
Heat Score 76 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
34645
KAEX is a patent pending nutraceutical / otc pharmaceutical
- Pedro Schmidt: Chief Executive Officer
- William Reinecke: Chief Supply Chain Officer
About the Company
KAEX® basic is a nutritional supplement that reloads the body with vital elements after intense training or social drinking, thereby improving regeneration and mitigating mental and physical fatigue the next day. After partying, i.e., excessive alcohol consumption, KAEX® basic reduces damages to the body by preventing nutritional deficiencies and
can be complemented with KAEX® dolo - an OTC pharmaceutical that gives symptomatic relief to hangover symptoms - making it the safest and efficacious hangover treatment ever to be developed. In sports, KAEX® basic is increasingly being used by professional athletes.